Integrating Pharmacogenomic Insights in GLP-1 Receptor Agonist Therapy: Direct GLP1R and ARRB1 Variants and Indirect CYP2D6 Influences in Personalized Obesity Management.
Saved in:
| Title: | Integrating Pharmacogenomic Insights in GLP-1 Receptor Agonist Therapy: Direct GLP1R and ARRB1 Variants and Indirect CYP2D6 Influences in Personalized Obesity Management. |
|---|---|
| Authors: | Jayathilaka NS; Department of Pharmacy and Pharmaceutical Sciences, University of Sri Jayewardenepura, Gangodawila, Nugegoda, Sri Lanka., Weththasinghe AV; Department of Biomedical Sciences, Faculty of Health Sciences, KIU, Battaramulla, Sri Lanka., Ganamurali N; Helix Research Lab, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India., Sabarathinam S; Helix Research Lab, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India. |
| Source: | Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2026 Mar; Vol. 15 (3), pp. e1624. Date of Electronic Publication: 2025 Nov 14. |
| Publication Type: | Journal Article; Review; Systematic Review |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2160-7648 |
|---|---|
| DOI: | 10.1002/cpdd.1624 |
